Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cytokine & Growth Factor Reviews
|
March 21, 2008
Transformation, translation and TRAIL: an unexpected intersection
Shai White-Gilbertson, Semyon Rubinchik, Christina Voelkel-Johnson
BMC Biotechnology
|
February 14, 2007
Novel system uses probasin-based promoter, transcriptional silencers and amplification loop to induce high-level prostate expression
Jan Woraratanadharm, Semyon Rubinchik, Hong Yu, et al.
Current Treatment Options in Oncology
|
September 22, 2009
Human papillomavirus and oropharyngeal cancer: what you need to know in 2009
M Boyd Gillespie, Semyon Rubinchik, Brian Hoel, et al.
Cancer Gene Therapy
|
November 8, 2003
Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector
Semyon Rubinchik, Hong Yu, Jan Woraratanadharm, et al.
Journal of the South Carolina Medical Association (1975)
|
March 31, 2009
Human papillomavirus and head and neck cancer: a growing concern
M Boyd Gillespie, Jake Smith, Kevin Gibbs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 18, 2005
Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer
Yan Yan, Semyon Rubinchik, April L Wood, et al.
Arthritis and Rheumatism
|
May 18, 2004
An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma
Jaspreet Pannu, Elizabeth Gore-Hyer, Masayoshi Yamanaka, et al.
Infectious Diseases
|
January 11, 2018
Retinoid Expression in Onchocercal Skin Disease: Pilot Study
Anthony R Mawson, Williams H Makunde, Alan D Penman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2005
Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma
Yan Yan, Semyon Rubinchik, Patricia M Watson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 24, 2006
Involvement of sphingolipids in apoptin-induced cell killing
Xiang Liu, Youssef H Zeidan, Saeed Elojeimy, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cytokine & Growth Factor Reviews
|
March 21, 2008
Transformation, translation and TRAIL: an unexpected intersection
Shai White-Gilbertson, Semyon Rubinchik, Christina Voelkel-Johnson
BMC Biotechnology
|
February 14, 2007
Novel system uses probasin-based promoter, transcriptional silencers and amplification loop to induce high-level prostate expression
Jan Woraratanadharm, Semyon Rubinchik, Hong Yu, et al.
Current Treatment Options in Oncology
|
September 22, 2009
Human papillomavirus and oropharyngeal cancer: what you need to know in 2009
M Boyd Gillespie, Semyon Rubinchik, Brian Hoel, et al.
Cancer Gene Therapy
|
November 8, 2003
Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector
Semyon Rubinchik, Hong Yu, Jan Woraratanadharm, et al.
Journal of the South Carolina Medical Association (1975)
|
March 31, 2009
Human papillomavirus and head and neck cancer: a growing concern
M Boyd Gillespie, Jake Smith, Kevin Gibbs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 18, 2005
Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer
Yan Yan, Semyon Rubinchik, April L Wood, et al.
Arthritis and Rheumatism
|
May 18, 2004
An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma
Jaspreet Pannu, Elizabeth Gore-Hyer, Masayoshi Yamanaka, et al.
Infectious Diseases
|
January 11, 2018
Retinoid Expression in Onchocercal Skin Disease: Pilot Study
Anthony R Mawson, Williams H Makunde, Alan D Penman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2005
Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma
Yan Yan, Semyon Rubinchik, Patricia M Watson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 24, 2006
Involvement of sphingolipids in apoptin-induced cell killing
Xiang Liu, Youssef H Zeidan, Saeed Elojeimy, et al.
Page
of 2